March 12th 2025
Industry 4.0 is driving adoption in the pharma industry for smart equipment and tools that will advance manufacturing.
Reaction Biology Acquires Bioassay GmbH for Increasing Large Molecule Capabilities
December 5th 2022In addition, personnel, equipment, and facilities from the acquired companies will expand Reaction Biology’s presence in Germany while enabling its global customers to leverage Bioassay’s expansive portfolio of regulated clinical and commercial services.